Status:
COMPLETED
Flagyl Microbiome in Crohn's Disease
Lead Sponsor:
University of Louisville
Conditions:
Crohn Disease
Eligibility:
All Genders
20-80 years
Phase:
PHASE4
Brief Summary
This study will compare the types of bacteria in the colon before and after colon resection surgery. The investigator will also compare standard post-operative antibiotic treatment to flagyl (metronid...
Detailed Description
Participants who are scheduled for colon resection for Crohn's disease will be invited to take part in this randomized study. Participants will be randomized 1:1 to either Metronidazole 250 mg three t...
Eligibility Criteria
Inclusion
- 20-80 years old who is deemed an acceptable surgical candidate for ileocolic resection.
Exclusion
- any patients that are dependent on total parenteral nutrition and unable to tolerate oral intake
- patients who will undergo resection but will have an ileostomy created
- patients on maintenance antibiotics for their disease
Key Trial Info
Start Date :
March 21 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 15 2023
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT04682522
Start Date
March 21 2021
End Date
August 15 2023
Last Update
October 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Surgical Associates
Louisville, Kentucky, United States, 40202